4.6 Article

Identification of 2,4-Diaminoquinazoline Derivative as a Potential Small-Molecule Inhibitor against Chikungunya and Ross River Viruses

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

A strategy for evaluating potential antiviral resistance to small molecule drugs and application to SARS-CoV-2

Karen Sargsyan et al.

Summary: Inferences about viral fitness cannot be made solely from mutagenesis studies of an isolated viral protein. A systematic analysis is lacking in identifying mutations that enhance virus fitness while reducing drug effectiveness. This study presents a general strategy to identify viral mutations that may decrease the efficacy of antiviral drugs targeting M-pro, PLpro, and RdRp in SARS-CoV-2. By analyzing drug-interacting virus residues and selection pressure of virus residues, potential drug target regions and antiviral resistance can be identified. This strategy utilizing genomic sequence and protein structure databases can quickly assess the fitness of emerging virus variants and guide future antiviral drug design.

SCIENTIFIC REPORTS (2023)

Article Medicine, General & Internal

Chikungunya fever

Koen Bartholomeeusen et al.

Summary: Chikungunya virus is a widespread and recurring infectious disease that causes severe joint and muscle pain. It is transmitted by Aedes mosquitoes and has been causing outbreaks in various regions due to climate change and globalization. With no specific treatment or vaccines available, surveillance and vector control measures are crucial in preventing further re-emergence and epidemics.

NATURE REVIEWS DISEASE PRIMERS (2023)

Review Biochemistry & Molecular Biology

Quinazoline Based HDAC Dual Inhibitors as Potential Anti-Cancer Agents

Jyothi Dhuguru et al.

Summary: Cancer, the second leading cause of death worldwide, remains a devastating disease due to drug resistance developed by cancer cells. Quinazolines, versatile and privileged nitrogen compounds, have shown promising therapeutic activity against cancer. Histone deacetylases (HDACs) have emerged as an important target in cancer drug development, and dual inhibitors based on HDACs are gaining significance.

MOLECULES (2022)

Review Pharmacology & Pharmacy

Recent advances in developing small-molecule inhibitors against SARS-CoV-2

Rong Xiang et al.

Summary: The COVID-19 pandemic has caused chaos worldwide, with vaccines in distribution but treatment methods lagging behind. Researchers are working hard to understand the virus and develop effective treatments.

ACTA PHARMACEUTICA SINICA B (2022)

Review Medicine, Research & Experimental

Recent advances in small-molecular therapeutics for COVID-19

Lei Zhong et al.

Summary: The COVID-19 pandemic has posed a major global health challenge, leading to efforts in developing antiviral strategies and therapeutic drugs. This comprehensive review focuses on small molecular anti-SARS-CoV-2 agents, discussing approved drugs and important candidates based on different target classifications. The future research and development of anti-SARS-CoV-2 drugs are also examined, offering hope for conquering COVID-19.

PRECISION CLINICAL MEDICINE (2022)

Review Biochemistry & Molecular Biology

Small molecules in the treatment of COVID-19

Sibei Lei et al.

Summary: This review discusses the current progress in the development of small molecules for the treatment of COVID-19. Various strategies, including computer-aided compound design, natural product discovery, drug repurposing, and combination therapy, have been employed. Some small molecules, such as remdesivir and paxlovid, have shown efficacy against COVID-19 and have been authorized for emergency use in multiple countries. However, novel strategies are still needed due to the epidemiological characteristics and variability of SARS-CoV-2.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Review Chemistry, Medicinal

Small Molecule Inhibitors of Influenza Virus Entry

Zhaoyu Chen et al.

Summary: This review summarizes the latest advances in the development of small molecule inhibitors targeting HA, including the structural basis and mode of action of these inhibitors, and looks forward to the development of more potent anti-influenza drugs in the future.

PHARMACEUTICALS (2021)

Review Pharmacology & Pharmacy

Small-molecule Antiviral Agents in Ongoing Clinical Trials for COVID-19

Cagla Begum Apaydin et al.

Summary: The COVID-19 pandemic caused by SARS-CoV-2 has posed a global challenge, with the urgent need for effective drugs for prevention and treatment. Currently, repurposed small-molecule antiviral agents are being investigated in clinical trials, showing potential therapeutic effects.

CURRENT DRUG TARGETS (2021)

Review Chemistry, Multidisciplinary

Quinazoline Derivatives as Potential Therapeutic Agents in Urinary Bladder Cancer Therapy

Paulina Wdowiak et al.

Summary: Cancer diseases continue to be major health challenges worldwide despite advancements in diagnostics and medications. Bladder cancer, a complex disorder, can be categorized based on genetic backgrounds and clinical features. Targeted therapy focusing on specific molecular pathways shows promise in treating bladder cancer, with quinazoline derivatives being explored as potential anticancer drugs.

FRONTIERS IN CHEMISTRY (2021)

Review Microbiology

Ross River Virus Infection: A Cross-Disciplinary Review with a Veterinary Perspective

Ka Y. Yuen et al.

Summary: RRV infection is the most common arboviral disease in humans in Australia, with no approved therapeutics or vaccines currently available. Establishing an equine model may aid in better understanding the pathogenesis and immunology of RRV disease.

PATHOGENS (2021)

Article Chemistry, Multidisciplinary

Quinazoline Ligands Induce Cancer Cell Death through Selective STAT3 Inhibition and G-Quadruplex Stabilization

Jan Jamroskovic et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)

Article Multidisciplinary Sciences

Mxra8 is a receptor for multiple arthritogenic alphaviruses

Rong Zhang et al.

NATURE (2018)

Review Biochemistry & Molecular Biology

Influenza Virus: Small Molecule Therapeutics and Mechanisms of Antiviral Resistance

Julianna Han et al.

CURRENT MEDICINAL CHEMISTRY (2018)

Article Medicine, Research & Experimental

Progress of small molecular inhibitors in the development of anti-influenza virus agents

Xiaoai Wu et al.

THERANOSTICS (2017)

Article Pharmacology & Pharmacy

Vector-delivered artificial miRNA effectively inhibited replication of Chikungunya virus

Amrita Saha et al.

ANTIVIRAL RESEARCH (2016)

Review Infectious Diseases

Molecular epidemiology, evolution and phylogeny of Chikungunya virus: An updating review

Alessandra Lo Presti et al.

INFECTION GENETICS AND EVOLUTION (2016)

Review Biochemistry & Molecular Biology

Antiviral drug discovery: broad-spectrum drugs from nature

J. P. Martinez et al.

NATURAL PRODUCT REPORTS (2015)

Review Medicine, General & Internal

Chikungunya Virus and the Global Spread of a Mosquito-Borne Disease

Scott C. Weaver et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Chemistry, Multidisciplinary

SNAr reaction in aqueous medium in the presence of mixed organic and inorganic bases

Nilesh B. Shelke et al.

RSC ADVANCES (2015)

Review Biotechnology & Applied Microbiology

Risks to the Americas associated with the continued expansion of chikungunya virus

Ann M. Powers

JOURNAL OF GENERAL VIROLOGY (2015)

Editorial Material Infectious Diseases

Arrival of Chikungunya Virus in the New World: Prospects for Spread and Impact on Public Health

Scott C. Weaver

PLOS NEGLECTED TROPICAL DISEASES (2014)

Review Pharmacology & Pharmacy

Alphaviruses: Population genetics and determinants of emergence

Scott C. Weaver et al.

ANTIVIRAL RESEARCH (2012)

Editorial Material Virology

Chikungunya Disease and Chloroquine Treatment

Ilenia Delogu et al.

JOURNAL OF MEDICAL VIROLOGY (2011)

Review Virology

Replication cycle of chikungunya: A re-emerging arbovirus

Maxime Solignat et al.

VIROLOGY (2009)

Article Chemistry, Medicinal

Synthesis and antimalarial evaluation of novel pyridine quinoline hybrids

Badri Narayan Acharya et al.

MEDICINAL CHEMISTRY RESEARCH (2008)

Article Infectious Diseases

Ribavirin therapy for Chikungunya arthritis

Rajan Ravichandran et al.

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2008)

Article Virology

Evolutionary relationships and systematics of the alphaviruses

AM Powers et al.

JOURNAL OF VIROLOGY (2001)